The Hypercalcemia of Genitourinary Malignancy
- 1 March 1979
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 121 (3) , 259-261
- https://doi.org/10.1016/s0022-5347(17)56743-9
Abstract
The treatment of metastatic genitourinary malignancy must incorporate an understanding of refractory hypercalcemia which may be present. Tumors have been shown to produce parathyroid hormone, prostaglandins, proteins, and steroids, many of which may cause hypercalcemia. The best treatment is generally total excision of the malignancy. Three cases of patients with this syndrome are discussed.This publication has 26 references indexed in Scilit:
- Hypercalcemia and MalignancyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1976
- Evidence for the Secretion of an Osteoclast Stimulating Factor in MyelomaNew England Journal of Medicine, 1974
- Indomethacin-Responsive Hypercalcemia in a Patient with Renal-Cell AdenocarcinomaNew England Journal of Medicine, 1974
- Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant diseaseThe American Journal of Medicine, 1974
- Plasma Phosphate and Potassium Levels in the Hypercalcemia of Malignant DiseaseJournal of Clinical Endocrinology & Metabolism, 1973
- Hypercalcemia Associated with Neoplastic DiseaseAnnals of Internal Medicine, 1970
- Mithramycin treatment of hypercalcemiaCancer, 1970
- Hyperparathyroidism associated with malignant tumors of nonparathyroid originCancer, 1969
- IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIAThe Journal of Experimental Medicine, 1964
- Vicissitudes of Parathyroid SurgeryAnnals of Surgery, 1961